Consistently, in ovarian carcinoma tissues, tumor cells and stromal cells increased CCL5 after cisplatin treatment, and cisplatin-resistant patients had high CCL5 levels that correlated with cancer stage [62]. Here, CCL5 is linked to neoplasm.